Impact of vitamin D on COVID-19 and other viral diseases

doi:10.5501/wjv.v13.i4.100356

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (398)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

319

Sum=331

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=51

Dec 25, 2024 (publication date) through Nov 18, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Virol. Dec 25, 2024; 13(4): 100356
Published online Dec 25, 2024. doi: 10.5501/wjv.v13.i4.100356

Impact of vitamin D on COVID-19 and other viral diseases

Basavraj S Nagoba, Ajay M Gavkare, Abhijit S Rayate, Neeta Nanaware, Sachin Bhavthankar

Basavraj S Nagoba, Department of Microbiology, Maharashtra Institute of Medical Sciences and Research, Latur 413531, India

Ajay M Gavkare, Department of Physiology, Maharashtra Institute of Medical Sciences and Research, Latur 413531, India

Abhijit S Rayate, Department of Surgery, Maharashtra Institute of Medical Sciences and Research, Latur 413531, India

Neeta Nanaware, Department of Physiology, Vilasrao Deshmukh Government Medical College, Latur 413512, Maharashtra, India

Sachin Bhavthankar, Department of Biochemistry, MIMSR Medical College, Latur 413512, India

Author contributions: Nagoba BS designed the overall concept and outline of the manuscript; Gavkare AM, Rayate AS, Nanaware N, and Bhavthankar S contributed to the discussion and design of the manuscript; Nagoba BS, Gavkare AM, and Rayate AS contributed to the writing and editing of the manuscript and literature review; All authors contributed to finalizing the manuscript.

Conflict-of-interest statement: The authors have no conflicts of interest to declare.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Basavraj S Nagoba, PhD, Professor, Department of Microbiology, Maharashtra Institute of Medical Sciences and Research, Vishwanathpuram, Ambajogai Road, Latur 413531, India. dr_bsnagoba@yahoo.com

Received: August 14, 2024
Revised: September 10, 2024
Accepted: September 27, 2024
Published online: December 25, 2024
Processing time: 65 Days and 1 Hours

Core Tip

Core Tip: Amidst the global health crisis, where coronavirus disease 2019 has claimed millions of lives and disrupted the very fabric of society, the quest for effective prophylactic and therapeutic strategies has become paramount. Vitamin D, a secosteroid with profound immunomodulatory effects, emerges as a molecule of consequence in this narrative. However, the scientific discourse must be unanimous, as current literature presents conflicting evidence and viewpoints reflecting the dynamic nature of scientific inquiry.